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Introduction
Activation of phosphatidylinositol (PI)-3-kinase and small 
  GTPases at the cell membrane controls various intracellular 
events, including cell–cell junction formation (Bershadsky, 2004), 
extension of the leading edge (Ridley et al., 2003), and infectious 
processes of pathogens (Cossart and Sansonetti, 2004). Activation 
of PI-3-OH kinase and subsequent PIP3 production activates Rac 
through PIP3 binding to Rac guanine nucleotide exchange factors 
(Rickert et al., 2000; Chung et al., 2001). PIP3 is a lipid compo-
nent of the cell membrane, and Rac is integrated into the mem-
brane via lipid modifi  cation (Hall, 1998). Therefore, the site of 
action downstream of PIP3 and Rac should be the membrane.
WAVE2 belongs to the Wiskott-Aldrich syndrome protein 
(WASP) family of proteins, which activate the actin-related 
  protein (Arp) 2/3 complex to stimulate signal-induced actin 
  polymerization. Five WASP family proteins have been identi-
fi  ed, and WAVE1, WAVE2, and neural WASP (N-WASP) are 
expressed ubiquitously (Suetsugu et al., 1999; Takenawa and 
Miki, 2001). Studies of cells from WAVE1, WAVE2, and 
N-WASP knockout mice have shown that WAVE2 is the protein 
that activates the Arp2/3 complex downstream of the small 
GTPase Rac (Snapper et al., 2001; Suetsugu and Takenawa, 
2003; Yan et al., 2003). We have reported that WAVE2 is a PIP3-
binding protein, although PIP3 alone was not involved in regu-
lating the ability of WAVE2 to activate the Arp2/3 complex 
(Oikawa et al., 2004).
A large protein complex has been proposed to suppress 
WAVE1 activity by trans-inhibition in which a trimeric protein 
complex, including PIR121/Sra1, Nap1, and Abi, binds to 
WAVE1 and suppresses WAVE1 activity (Eden et al., 2002). 
WAVE2 also forms a large protein complex including HSPC300, 
Abi1, Nap1, and Sra1/PIR121 (Kunda et al., 2003; Rogers et al., 
2003; Gautreau et al., 2004; Innocenti et al., 2004; Steffen et al., 
2004). Studies of cultured cells have shown that Sra1, Nap1, 
and Abi are involved in stabilizing WAVE2; the knockdown of 
Abi1, Nap1, or Sra1 results in decreased amounts of all of the 
proteins in the WAVE2 complex (Kunda et al., 2003; Rogers 
et al., 2003; Steffen et al., 2004). Among proteins in the WAVE2 
complex, Abi1 and HSPC300 bind directly to the NH2-terminal 
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W
AVE2 activates the actin-related protein (Arp) 
2/3 complex for Rac-induced actin polymer-
ization during lamellipodium formation and 
exists as a large WAVE2 protein complex with Sra1/
PIR121, Nap1, Abi1, and HSPC300. IRSp53 binds to 
both Rac and Cdc42 and is proposed to link Rac to 
WAVE2. We found that the knockdown of IRSp53 by RNA 
interference decreased lamellipodium formation without 
a decrease in the amount of WAVE2 complex. Localization
of WAVE2 at the cell periphery was retained in IRSp53 
knockdown cells. Moreover, activated Cdc42 but not Rac 
weakened the association between WAVE2 and IRSp53. 
When we measured Arp2/3 activation in vitro, the 
WAVE2 complex isolated from the membrane fraction of 
cells was fully active in an IRSp53-dependent manner but 
WAVE2 isolated from the cytosol was not. Puriﬁ  ed WAVE2 
and puriﬁ  ed WAVE2 complex were activated by IRSp53 
in a Rac-dependent manner with PIP3-containing liposomes. 
Therefore, IRSp53 optimizes the activity of the WAVE2 
complex in the presence of activated Rac and PIP3.
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WAVE homology domain (WHD) of WAVE2. WHD-mediated 
association with Abi1/2 also contributes to the localization of 
WAVE2 at the leading edge of lamellipodia (Leng et al., 2005). 
However, purifi  ed HSPC300, Abi1, Nap1, and Sra1/PIR121 do 
not suppress the activity of WAVE2 purifi  ed from a baculovirus 
system (Gautreau et al., 2004; Innocenti et al., 2004).   Therefore, 
trans-inhibition does not appear to occur with WAVE2 purifi  ed 
from baculovirus. The activity of the native WAVE2 complex 
has yet to be examined.
A WAVE2-binding protein that is not included in the 
aforementioned protein complex is IRSp53/BAIAP2/Bap2α 
(Miki et al., 2000). The Src homology 3 (SH3) domain of 
IRSp53 binds to WAVE2, and the NH2-terminal Rac-binding 
(RCB) domain (residues 1–228) binds to Rac (Miki et al., 2000; 
Choi et al., 2005). Thus, IRSp53 might be the link between Rac 
and WAVE2 that is involved in lamellipodium formation. The 
NH2-terminal region of IRSp53 (residues 1–250), including the 
RCB domain, is termed the IRSp53/missing in metastasis 
  homology domain (IMD). The IMD possesses actin fi  lament 
bundling activity, and the overexpression of IRSp53 induces 
microspike/fi  lopodium formation (Govind et al., 2001; Krugmann 
et al., 2001; Millard et al., 2005). Furthermore, Cdc42 does not 
bind to the RCB domain but binds to the Cdc42–Rac interactive 
binding motif between the RCB and SH3 domains (Govind 
et al., 2001; Krugmann et al., 2001). These fi  ndings have not 
been reconciled, and the role of IRSp53 in actin cytoskeletal 
  reorganization remains to be clarifi  ed.
In this study, we investigated the activity of the WAVE2 
complex purifi  ed from various cellular preparations and exam-
ined the contributions of WAVE2-binding proteins to the regu-
lation of WAVE2 downstream of Rac.
Results
Localization of WAVE2 and IRSp53
To purify the WAVE2 complex from cultured cells, we sta-
bly expressed WAVE2 tagged with FLAG in A431 cells. The 
amount of WAVE2 in the FLAG-WAVE2–expressing cell line 
was approximately twice that of control vector–transfected 
cells (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200509067/DC1). This cell line and the control cell line 
were used throughout this study. WAVE2 in FLAG-WAVE2–
  expressing cells was localized similar to WAVE2 in control A431 
cells (Fig. S1 A). A signifi  cant portion of endogenous WAVE2 
localized at cell–cell junctions and lamellipodia (Fig. 1 A).
In cells with decreased Abi1 expression by RNAi, the 
amount of WAVE2 was signifi   cantly decreased in FLAG-
WAVE2–expressing cells, indicating that tagged WAVE2 under 
stable expression behaved similarly to endogenous WAVE2 
(Fig. 1 C). WAVE2 tagged with GFP did not localize properly 
in the absence of Abi1, but it localized in a manner similar to 
endogenous WAVE2 in the presence of Abi1 as reported previ-
ously, indicating that Abi1 is essential for the localization of 
WAVE2 (Fig. 1 B; Steffen et al., 2004; Leng et al., 2005).
We previously identifi  ed IRSp53 as a WAVE2-binding pro-
tein. The presence of IRSp53 splice variants was indicated by the 
presence of IRSp53 bands at two positions on the Western blot. 
IRSp53 was also localized at cell–cell junctions and lamelli-
podia (Fig. 1 A). In cells with decreased IRSp53 expression, the 
amount of WAVE2, Abi1, Nap1, or Sra1 in whole cell lysates 
was not altered (Fig. 1 C), and WAVE2 remained at the cell pe-
riphery (Fig. 1 A). The amount of Abi in the WAVE2 protein 
complex was not signifi  cantly altered by IRSp53 knockdown 
(Fig. S1 B), as indicated by immunoprecipitation with anti-
FLAG antibody.
IRSp53 participates 
in lamellipodia formation
In cells subjected to IRSp53 RNAi, lamellipodium formation in 
response to EGF treatment or expression of constitutively active 
(CA) Rac (Rac CA) was signifi  cantly decreased (Figs. 1 A and 2, 
A and B). Time-lapse analysis confi  rmed the decrease in 
  lamellipodium formation, especially the speed of extension at 
the leading edge of cells treated with IRSp53 RNAi (Fig. 1 D 
and Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200509067/DC1). The reduction in speed of the extension 
of cells treated with Abi1 RNAi was more drastic than of cells 
treated with IRSp53 RNAi (Fig. 1 D and Video 1).
A similar protein, insulin receptor tyrosine kinase sub-
strate (IRTKS), was also found in A431 cells by RT-PCR analy-
sis (Fig. S1 B). RNAi for IRTKS was performed in A431 cells, 
and specifi  c decreases in mRNA were observed for IRTKS (Fig. 
S1 B). However, the reduction of IRTKS did not affect ruffl  e 
formation (Fig. 1 A).
We then examined whether IRSp53 is essential for ruffl  e 
formation in fi  broblasts. Mouse embryonic fi  broblasts (MEFs) 
from WAVE2 knockout mice were used. The expression of full-
length (wild type) WAVE2 restored ruffl  e formation upon the 
expression of Rac CA, but the expression of ∆PR WAVE2 with 
a deleted proline-rich region (IRSp53-binding region) or of 
∆WHD WAVE2 with a deleted WHD region (Abi1-binding 
  region) did not (Fig. S2, available at http://www.jcb.org/cgi/ 
content/full/jcb.200509067/DC1). The A5 mutant of WAVE2 
(defective in binding to PIP3; Oikawa et al., 2004) also failed 
to restore ruffl  e formation (Fig. S2). Importantly, ∆PR WAVE2 
  localized at the cell periphery, whereas ∆WHD WAVE2 did not. 
Consistent with the localization of WAVE2 at the cell periphery 
in IRSp53 RNAi A431 cells (Fig. 1 A), IRSp53 was not essen-
tial for the localization of WAVE2. In MEFs, ruffl  e formation 
was severely impaired by Abi1 RNAi (Fig. S2 and Video 2). 
IRSp53 RNAi caused a decrease of ruffl  e formation and exten-
sion speed of the leading edge, indicating the involvement of 
IRSp53 in ruffl  e formation in fi  broblasts (Fig. S2 and Video 2).
Negative regulation of WAVE2–IRSp53 
association by Cdc42
Because IRSp53 binds to both Rac and Cdc42, we examined the 
interaction between IRSp53 and WAVE2 upon the expression of 
CA mutants. In the presence of Cdc42 CA, the interaction was 
signifi  cantly decreased (Fig. 2, C and D). In contrast, the inter-
action between IRSp53 and WAVE2 was not signifi  cantly per-
turbed by Rac CA expression (Fig. 2, C and D). The interaction 
between purifi  ed WAVE2 and purifi  ed IRSp53 was also de-
creased in the presence of GTPγS-loaded Cdc42 but not in the WAVE2 COMPLEX FROM THE CYTOSOL AND MEMBRANE • SUETSUGU ET AL. 573
presence of Rac (Fig. 2 E). Therefore, Cdc42 appears to nega-
tively regulate the binding of IRSp53 to WAVE2.
Enrichment of IRSp53 at the membrane 
and translocation of some WAVE2 
to the membrane upon stimulation
We fractionated cells and examined the subcellular localization 
of proteins by conventional ultracentrifugation (Fig. 3 A). All of 
the proteins analyzed were found in all cell fractions, including 
the cytosol, membrane, and nucleus (unpublished data). WAVE2 
was somewhat enriched in the membrane fraction; the mem-
brane fraction contained 30% more WAVE2 than the cytosol 
fraction. Abi1 was much more enriched in the membrane frac-
tion, as the membrane fraction contained approximately twice 
that of the cytosol fraction. Most IRSp53 was present in the 
membrane fraction, as it contained four times that of the   cytosol 
fraction (Fig. 3 A).
We then examined whether ruffl  e-inducing stimuli could 
translocate WAVE2 from the cytosol and nucleus to the membrane. 
Upon EGF treatment, the amount of WAVE2 in the membrane 
fraction was increased 17% (Fig. 3, C and D). When Rac CA was 
expressed, the amount of WAVE2 in the membrane fraction in-
creased 26% (Fig. 3 B). However, when dominant-negative (DN) 
Rac (Rac DN) was expressed, the amount of WAVE2 in 
the membrane fraction decreased 16% (Fig. 3, B and D). The 
  expression of Cdc42 CA also decreased the membrane localiza-
tion of WAVE2 (Fig. 3 D and S1 E). WAVE2 in the cytosol frac-
tion was not signifi  cantly reduced in response to these stimuli, 
presumably because of the presence of nuclear WAVE2 trans-
located to the cytosol, as shown by antibody staining of the cells 
(unpublished data). Thus, ruffl  e-inducing stimuli induced the 
translocation of some WAVE2 to the membrane (Fig. 3 E). We 
then examined the contribution of IRSp53 to the membrane lo-
calization of WAVE2. When we knocked down IRSp53 by RNAi, 
the amount of WAVE2 at the membrane decreased by 30–40% 
(Fig. 3, B and D). WAVE2 was not involved in the membrane lo-
calization of IRSp53 because RNAi of WAVE2 did not have an 
effect on the amount of IRSp53 in the membrane (Fig. 3 E).
Figure 1.  Localization of WAVE2 and IRSp53 in A431 cells. (A) Localization of WAVE2 and IRSp53 in EGF-stimulated A431 cells treated with control, 
IRSp53, or IRTKS stealth RNAi was examined by immunoﬂ  uorescence with anti-WAVE2 antibody or anti-IRSp53 antibody (M051-3). Actin ﬁ  laments stained 
with phalloidin are also shown. WAVE2 and IRSp53 were localized at rufﬂ  es (arrowheads) and cell–cell junctions (arrows). (B) Localization of WAVE2-GFP 
in A431 cells with reduced IRSp53 or Abi1 expression. A431 cells were transfected with WAVE2-GFP expression vector and pSuper vectors for control, 
IRSp53, or Abi1 RNAi. GFP signal was enhanced by anti-GFP staining. Bar, 40 μm. (C) Western blot analysis of whole cell lysates from control, IRSp53, 
or Abi1 stealth RNAi-treated A431 cells. Western blot with anti-actin antibody is shown as a loading control. (D) Quantiﬁ  cation of the speed of the leading 
edge extension of EGF-stimulated A431 cells. Signiﬁ  cant difference was analyzed by the t test. Error bars represent SD.JCB • VOLUME 173 • NUMBER 4 • 2006  574
Characterization of the WAVE2 complex 
from the membrane and cytosol fractions
To determine the relationship between protein localization and 
Arp2/3 complex activation, we purifi  ed WAVE2 protein com-
plex with a FLAG tag. We purifi  ed WAVE2 complex from the 
cytosolic fraction; however, we were unable to resolubilize the 
pelleted membrane fraction. Therefore, we purifi  ed the WAVE2 
complex from cell lysates, including the membrane fraction, 
with Triton X-100. Thus, WAVE2 complex from the Triton 
X-100 fraction contained cytosolic and membrane WAVE2 at a 
ratio of  1:1.3 (Fig. 3 A).
Examination of the proteins in the WAVE2 complex in 
the Triton X-100 fraction by Western blotting showed the pres-
ence of Abi1 and IRSp53, as reported previously (Fig. 4 A; Miki 
et al., 2000; Innocenti et al., 2004; Steffen et al., 2004). Abi1 
also exists as several isoforms and splice variants, and several 
bands were identifi  ed. EGF stimulation induces the phosphor-
ylation of WAVE2 (Miki et al., 1999). However, signifi  cant 
alterations in the amounts of Abi1 and IRSp53 in WAVE2 
immuno precipitates were not observed in response to EGF stim-
ulation. Specifi  c binding of IRSp53 and Abi to WAVE2 was con-
fi  rmed in experiments with vector-transfected cells (Fig. 4 A). 
Figure 2.  Involvement of IRSp53 in Rac and EGF-induced rufﬂ  e formation in A431 cells. (A) A431 cells were transfected with constitutively active Rac 
(Rac CA) and control or IRSp53 RNAi pSuper vector. (left) Actin ﬁ  lament (red; phalloidin) and WAVE2 localization (green; anti-WAVE2) was then analyzed. 
Rac expression is shown in blue. (right) Quantiﬁ  cation of membrane rufﬂ  es in transfected cells. Three independent experiments were performed. (B) EGF-
stimulated A431 cells transfected with IRSp53 RNAi pSuper vector alone or plus RNAi-resistant GFP-IRSp53 expression vector. (left) Actin ﬁ  lament (red; 
phalloidin) and GFP localization (green; anti-GFP) were then analyzed. (A and B) Bars, 40 μm. (right) Quantiﬁ  cation of membrane rufﬂ  es as in A. (C and D) 
A431 cells stably expressing FLAG-tagged WAVE2 were transfected with Rac CA or Cdc42 CA expression vector. Then, IRSp53 in the FLAG-WAVE2 
  precipitates was examined by Western blot analysis (C). The amount of IRSp53 relative to WAVE2 in the precipitate was quantiﬁ  ed by densitometry (D). 
Three independent experiments were performed. (E) GST fusion protein of WAVE2 was immobilized, and puriﬁ  ed IRSp53 was incubated with GTPγS-
loaded Rac or Cdc42. After washing, bound IRSp53 was examined by Western blotting. Error bars represent SD.WAVE2 COMPLEX FROM THE CYTOSOL AND MEMBRANE • SUETSUGU ET AL. 575
Other WASP family proteins, including N-WASP and WAVE1, 
were not identifi  ed in the WAVE2 complex (Fig. 4, A and B).
Proteins coeluted with WAVE2 did not differ signifi  cantly 
in response to EGF stimulation. Because WAVE2 in the mem-
brane was increased only 17% upon EGF stimulation (Fig. 3), 
a lack of difference in the WAVE2 complex before and after 
stimulation may be reasonable. The expression of Rac CA or 
Rac DN also did not cause signifi  cant change in the WAVE2 
complex (unpublished data). Mass spectrometry and Western 
blotting identifi  ed PIR121/Sra1, Nap1/p125NckAP1, and Abi1/
Abi2/E3B1 in all WAVE2 complex preparations as reported 
previously (Innocenti et al., 2004; Steffen et al., 2004; unpub-
lished data). We also identifi  ed IRSp53 comigrating with Abi1 
and IgG in the Triton X-100 fraction only by SDS-PAGE inde-
pendently of EGF stimulation (Fig. 4 B, bottom).
From the band intensity in Coomassie brilliant blue–
stained gels (unpublished data), the molar ratio of Abi, Nap1, or 
Sra1 to FLAG-WAVE2 was determined to be  0.5–0.6 (Fig. 4 C), 
suggesting the presence of monomeric WAVE2 upon FLAG-
WAVE2 expression. Importantly, the amounts of PIR121/Sra1, 
Nap1, and Abi in the WAVE2 complex were consistently inde-
pendent of stimuli or subcellular localization, indicating stable 
formation of the WAVE2 complex.
The band corresponding to IRSp53 was not apparent in 
silver-stained gels; there was no apparent difference in band in-
tensities between the Triton X-100 and the cytosolic WAVE2 
complex in silver-stained gels despite the detection of IRSp53 
only in the Triton X-100 fraction by Western blotting. The mo-
lar ratio of IRSp53 to WAVE2 in the Triton X-100 fraction of 
purifi  ed WAVE2 complex from cells was 0.0005 by quantitative 
Western blotting with standard proteins purifi  ed from baculo-
virus (unpublished data). Because the ratio of cytosolic to mem-
brane WAVE2 was 1.3, the molar ratio of IRSp53 to WAVE2 in 
the membrane was estimated to be 0.001, suggesting a transient 
interaction between IRSp53 and WAVE2.
Measurement of the binding constant 
and the intracellular concentrations 
of WAVE2 and IRSp53
Abi1 and IRSp53 bind to WAVE2 via the coiled-coil region 
of Abi1 and the SH3 domain of IRSp53 (Miki et al., 2000; 
Echarri et al., 2004). We measured the dissociation constant 
Figure 3.  Role of IRSp53 in WAVE2 localization. (A–D) Cells 
were fractionated by ultracentrifugation, and the proteins in 
each fraction were analyzed by Western blotting. (A) Proteins 
in membrane and cytosol fractions of serum-starved A431 
cells. The ratios of the protein levels were examined by densi-
tometry and expressed with SD. (B) Proteins in the membrane 
fraction of A431 cells transfected with expression vectors for 
constitutively active Rac (Rac CA), dominant-negative Rac 
(Rac DN), control RNAi, and/or IRSp53 RNAi pSuper vector. 
Stealth RNAi was applied for cells treated with EGF. (C) Pro-
teins in the membrane fraction of EGF-stimulated or unstimu-
lated A431 cells. (D) Quantiﬁ   cation of WAVE2 in the 
membrane fractions. (E) Proteins in the membrane fraction of 
EGF-stimulated A431 cells transfected with stealth RNAi tar-
geted to WAVE2. *, P < 0.005; **, P < 0.05 by t test. Error 
bars represent SD.JCB • VOLUME 173 • NUMBER 4 • 2006  576
(Kd)   between full-length WAVE2 and the coiled-coil region of 
Abi1 (aa 6–124) or between full-length WAVE2 and the SH3 
domain of IRSp53 (aa 363–521) with a dual polarization inter-
ferometer, and the Kds were determined to be 0.6 and 5.7 μM, 
respectively (Fig. 4 D).
We then measured the intracellular concentration of 
WAVE2 or IRSp53 by quantitative Western blotting with puri-
fi  ed WAVE2 or IRSp53 as standards. WAVE2 concentration in 
whole cell lysates was 30–50 nM, whereas that of IRSp53 was 
150–300 nM. Given the Kd of 5.7 μM for WAVE2 and IRSp53, 
only 2.5 nM WAVE2 was associated with IRSp53 in solution at 
WAVE2 and IRSp53 concentrations of 50 and 300 nM, respec-
tively. Therefore, the Kd value between IRSp53 and WAVE2 
suggests that these two proteins associate with the aid of other 
molecules such as Rac or PIP3 or in a restricted location such as 
the cell membrane. Even if WAVE2 and IRSp53 associate under 
limited situations, the 10-fold difference in Kd values appears 
to explain the lesser amount of IRSp53 in the aforementioned 
purifi  ed WAVE2 complex. Three washes in 10-fold volumes of 
buffer will result in a 1,000-fold difference in protein amount.
Similar activity of the WAVE2 complex 
to that of the WAVE2 monomer
Most WAVE2 molecules are reported to complex with Sra1/
PIR121, Nap1, and Abi1. We fractionated lysates of control 
A431 cells or cells expressing FLAG-tagged WAVE2 in a 3–30% 
sucrose gradient. Most of the WAVE2 in control cells formed a 
protein complex, but a small population of monomeric WAVE2 
was found (Fig. 5 A). Approximately half of the WAVE2 in cells 
stably expressing FLAG-WAVE2 was monomeric and not asso-
ciated with Abi1 (Fig. 5 B). Therefore, the presence of mono-
meric WAVE2 in cells expressing FLAG-WAVE2 is caused by 
the ectopic expression of WAVE2. We also created a WAVE2 
knockout MEF cell line stably expressing FLAG-WAVE2 in 
Figure 4. WAVE2 complex puriﬁ  ed  from 
A431 cells. (A) FLAG-tagged WAVE2 was 
  immunoprecipitated from A431 cells stably 
  expressing FLAG-WAVE2 or from control vec-
tor–transfected cells by FLAG afﬁ  nity immuno-
precipitation (IP). Speciﬁ   c association was 
examined by Western blot analysis. (B) WAVE2 
complex was puriﬁ  ed from A431 cells stably 
expressing FLAG-WAVE2 by FLAG afﬁ  nity im-
munoprecipitation. The Triton X-100 fraction 
indicates WAVE2 from both the cytosol and 
membrane fractions, and the cytosol fraction 
indicates WAVE2 from the cytosol fraction 
alone. WAVE2 complex from EGF-treated cells 
(EGF) or untreated cells (starved) are shown in 
silver-stained gels. The orders of the samples of 
Western blots are arranged to ﬁ  t the order of 
the samples of silver-stained gels. (C) Molar 
  ratio of the components of the WAVE2 complex 
shown in B. Molar ratio was determined as the 
band intensity of Coomassie brilliant blue–
stained gels (not depicted) divided by molecu-
lar weight. Tx, Triton X-100; cyt, cytosol. (D) 
The dissociation constants (Kd) of the indicated 
domains to WAVE2 were determined using a 
dual polarization interferometer. The represen-
tative response curves (top) used for the calcu-
lation of Kd (bottom) are shown. Error bars 
represent SD.WAVE2 COMPLEX FROM THE CYTOSOL AND MEMBRANE • SUETSUGU ET AL. 577
amounts similar to that of wild-type cells (Yamazaki et al., 
2005). Most of the WAVE2 in WAVE2 knockout cells express-
ing FLAG-WAVE2 formed a complex (Fig. 5 C) in a manner 
similar to wild-type cells (unpublished data). In all of the 
lysates we prepared, IRSp53 was not coeluted with WAVE2 
(Fig. 5, A–C), indicating that IRSp53–WAVE2 association is 
very weak or transient. As reported previously, Abi1 was essen-
tial for WAVE2 complex formation because RNAi of Abi1 
  increased the amount of monomeric WAVE2 compared with 
that of the WAVE2 complex (Fig. 5 D). In contrast, RNAi of 
IRSp53 did not signifi  cantly affect WAVE2 complex assembly 
(Fig. 5 E and Fig. S1 C).
We next examined the stability of the WAVE2 complex by 
sequential sucrose gradient. The high molecular weight fraction 
of the FLAG-WAVE2 preparation obtained from a sucrose gra-
dient was further subjected to another sucrose gradient (Fig. 
5 E), showing that the WAVE2 complex was stable without any 
dissociation of the components in the second sucrose gradient. 
We then examined the dependence of protein complex forma-
tion on WAVE2 localization or EGF stimulation. The amount 
of WAVE2 in the smaller molecular weight fraction was not 
  increased upon stimulation (Fig. 5, F–I; and Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200509067/DC1). 
A small population of IRSp53 was found in the WAVE2 complex 
fraction and monomeric WAVE2 fraction, but it appeared to 
  dissociate during fractionation (Fig. 5, F and H). Differences 
in the localization of WAVE2 (cytosolic or Triton X-100) did 
not result in differences in the amounts of the two populations 
of WAVE2 (Fig. 5, F–I; and Fig. S3). We added GTPγS-loaded 
Rac alone (Fig. 5 J and Fig. S3) or a combination of GTPγS-
loaded Rac, IRSp53, and PIP3-containing liposomes (Fig. 5 K 
and Fig. S3) to cell-purifi  ed WAVE2. However, no signifi  cant 
increase in WAVE2 in the smaller molecular weight fraction 
was observed.
To examine the dependence of activities on WAVE2 com-
plex formation, we analyzed the activity of each sucrose gradi-
ent fraction from Triton X-100 fractions of serum-starved cells 
in Arp2/3-mediated actin polymerization assays. As a control, 
actin polymerization was induced in sucrose gradients prepared 
in the absence of protein. Increased sucrose concentration de-
creased the rate of actin polymerization, but the maximum actin 
polymerization achieved was not altered (Fig. 5 L). When the 
rate of actin polymerization of each fraction was normalized to 
that induced by Arp2/3 alone, WAVE2 protein concentration, 
as determined by Western blotting, was associated with Arp2/3 
activation (Fig. 5, M and N). Therefore, actin polymerization 
between monomeric WAVE2 and the WAVE2 complex did not 
differ signifi  cantly.
High activity of WAVE2 complex from 
the membrane fraction independent 
of protein complex formation
Because we did not detect signifi  cant differences in Arp2/3 acti-
vation between the two WAVE2 populations, we examined the 
activity of the entire WAVE2 elution. We did not detect any sig-
nifi  cant alterations in actin polymerization in WAVE2 protein 
complexes alone (unpublished data). When we added purifi  ed 
Arp2/3, WAVE2 complex from various preparations showed 
Arp2/3 complex activation (Fig. 6, A and B). WAVE2 complex 
from the Triton X-100 fraction showed greater Arp2/3 complex 
activation than that from the cytosol fraction (Fig. 6 A). To 
 assess differences in activity more quantitatively, we determined 
concentration-dependent activation curves for WAVE2 com-
plexes from various preparations (Fig. 6 B). From these curves, 
we confi  rmed that WAVE2 complex from the Triton X-100 frac-
tion had greater activity than that from the cytosol fraction. 
WAVE2 complex activity from the Triton X-100 fraction was 
similar to that of the VCA domain of WAVE2 (Fig. 6 B). EGF 
stimulation did not alter WAVE2 activity. Thus, cytosolic 
WAVE2 was not fully activated but membrane WAVE2 was. 
  Because WAVE2 from the Triton X-100 fraction was fully 
  active and WAVE2 in the protein complex had similar activity to 
that of WAVE2 not in the complex (Fig. 5 H), WAVE2 in the 
protein complex may be fully activated.
We also measured the activity of the WAVE2 complex in 
MEFs. Almost all of the WAVE2 was complexed (Fig. 5 C). The 
activity of the WAVE2 complex prepared from the Triton X-100 
fraction was also higher than that of the cytosolic WAVE2 com-
plex, and no signifi  cant difference in the activities was induced 
by EGF stimulation (Fig. 6 C).
IRSp53-dependent activation 
of the WAVE2 complex
To determine the absence or presence of IRSp53, we performed 
RNAi experiments to decrease IRSp53 expression. WAVE2 
complex purifi  ed from the Triton X-100 fraction of cells with 
decreased IRSp53 expression by vector-based RNAi or by 
siRNA showed decreased Arp2/3 complex activation (Fig. 6, D 
and E; and not depicted). Restoration of IRSp53 in IRSp53 
RNAi cells restored WAVE2 activity (unpublished data). The 
activity of the cytosolic WAVE2 complex was not altered 
(  unpublished data), and the WAVE2 complex showed no detect-
able changes in silver-stained gels and in Western blot analysis 
in   response to RNAi of IRSp53 (Fig. S1 C).
We next examined whether exogenous IRSp53 activates 
the cytosolic WAVE2 complex. The addition of a 10-fold molar 
excess of purifi  ed IRSp53 to the cytosolic WAVE2 complex 
  activated the Arp2/3 complex (Fig. 6 F), strongly indicating that 
IRSp53 activates WAVE2 at the membrane.
Rac-, IRSp53-, and PIP3-dependent 
activation of WAVE2 independent 
of protein complex formation
To confi  rm the activation of WAVE2 by IRSp53, we prepared 
recombinant proteins (Fig. S4, available at http://www.jcb.org/
cgi/content/full/jcb.200509067/DC1). We examined whether 
IRSp53 was able to activate recombinant WAVE2 alone or the 
reconstituted WAVE2 complex (Fig. S4). We also examined 
the effects of PIP3-containing liposomes or control liposome 
composed of phosphatidylcholine (PC) and PI and that of lipi-
dated Rac. Recombinant WAVE2 alone was activated by 
IRSp53 in the presence of GTPγS-loaded Rac and PIP3-
  containing PC/PI liposomes (Fig. 7, A and C). However, acti-
vation was not observed with Cdc42 or with liposome lacking JCB • VOLUME 173 • NUMBER 4 • 2006  578
Figure 5.  Fractionation of cell lysate and puriﬁ  ed WAVE2 from A431 cells by sucrose gradient. (A–C) Cell lysates of control A431 cells (A), A431 cells 
stably expressing FLAG-tagged WAVE2 (B), and WAVE2 knockout MEF stably expressing FLAG-tagged WAVE2 (C) were fractionated by molecular weight 
in a 3–30% sucrose gradient, and each fraction was visualized by Western blotting. (D–K) Puriﬁ  ed WAVE2 from A431 cells stably expressing FLAG-tagged 
WAVE2 was fractionated. (D) WAVE2 puriﬁ  ed from the Triton X-100 fraction of pSuper vector–transfected cells of control, IRSp53, or Abi1 RNAi. (E) Se-
quential sucrose gradient fractionation. WAVE2 puriﬁ  ed from the Triton X-100 fraction was fractionated, and the high molecular weight fraction (fraction 
8–10) was further fractionated. Bar indicates the fractions that were used in the second sucrose gradient. (F) WAVE2 puriﬁ  ed from the Triton X-100 fraction 
of EGF-treated cells. (G) Cytosol fraction of EGF-treated cells. (H) Triton X-100 fraction of serum-starved cells, and (I) cytosol fraction of serum-starved cells. 
(J and K) WAVE2 from the cytosol fraction of serum-starved cells was incubated with GTPγS-loaded Rac (J) or GTPγS-loaded Rac, IRSp53, and PIP3 (K). (L and M) 
Activities of the WAVE2 monomer and WAVE2 complex were compared. (L) Sucrose gradient in the absence of protein was also used as a control. The 
axis of actin polymerization rate for VCA + Arp2/3 is on the right, and that for Arp2/3 alone is on the left. (M) Each sucrose gradient fraction of WAVE2 
from the Triton X-100 fraction of serum-starved cells was analyzed for Arp2/3 complex activation with 50 nM of puriﬁ  ed Arp2/3 complex and 2 μM of 
10% pyrene-labeled actin. The rate of actin polymerization at 10% polymerization was determined and plotted relative to fraction number. Arrows indicate 
the peak fraction of the activity of the Arp2/3 complex activation in N. (N) The value of slope in M was normalized to the value of Arp2/3 alone in L as 1 
(left axis) and was plotted with WAVE2 concentration determined by Western blotting followed by densitometry (right axis). Error bars represent SD.WAVE2 COMPLEX FROM THE CYTOSOL AND MEMBRANE • SUETSUGU ET AL. 579
Figure 6.  Arp2/3 complex activation by the WAVE2 complex. (A and D) WAVE2 complex puriﬁ  ed from the Triton X-100 or cytosol fraction with (EGF) or 
without stimulation (starved) of A431 cells (A) and from the Triton X-100 fraction of control or IRSp53 RNAi-treated cells (D) was analyzed for Arp2/3 com-
plex activation ability with 50 nM Arp2/3 complex and 2 μM of 10% pyrene-labeled actin. Actin polymerization was monitored by pyrene ﬂ  uorescence. 
The VCA fragment of WAVE2 was also analyzed for concentration-dependent activation of the Arp2/3 complex. (B and E) Dose-response curves for A and D 
show the change in ﬁ  lament elongation rate as a function of increasing concentrations of WAVE2 complex. Elongation rate was determined by the slope 
of ﬂ  uorescence change at 15% actin polymerization. (C) Dose-response curves show the change in ﬁ  lament elongation rate as a function of increasing con-
centrations of WAVE2 complex puriﬁ  ed from the Triton X-100 or cytosol fraction with (EGF) or without stimulation (starved) of WAVE2 knockout MEFs stably 
expressing FLAG-WAVE2. (F) WAVE2 complex puriﬁ  ed from the cytosol fraction was mixed with recombinant IRSp53 or GTPγS-loaded Rac, and Arp2/3 
complex activation was measured as in A. JCB • VOLUME 173 • NUMBER 4 • 2006  580
Figure 7.  Rac- and PIP3-dependent actin polymerization mediated by IRSp53 and WAVE2. (A) 40 nM of puriﬁ  ed recombinant WAVE2 was preincubated 
with 60 nM of recombinant IRSp53, 300 nM GTPγS-loaded Rac, 300 nM GTPγS-loaded Cdc42, 8 μM PIP3-containing PC/PI liposomes (PIP3/PC/PI), 
and/or PC/PI liposomes. Arp2/3 complex activation was determined with 50 nM Arp2/3 complex and 2 μM of 10% pyrene-labeled actin. (B) 40 nM of 
puriﬁ  ed recombinant WAVE2 coexpressed and copuriﬁ  ed with Abi1 that was incubated with recombinant PIR121 copuriﬁ  ed with 250 nM Nap1. Rac-, 
PIP3-, and IRSp53-dependenent Arp2/3 activation was examined as in A. (C) Concentration response of ﬁ  lament elongation rate dependent on IRSp53 
concentration. Puriﬁ  ed recombinant WAVE2 was incubated with various concentrations of IRSp53 in the absence or presence of PIP3/PC/PI liposome and 
GTPγS-loaded Rac or PC/PI liposomes alone. (D) Puriﬁ  ed recombinant wild-type or PIP3 binding-defective A5 mutant of WAVE2 was incubated with IRSp53 
in the absence or presence of PIP3/PC/PI liposome and GTPγS-loaded Rac. Filament elongation rate is shown with SD (error bars). (E) 100 nM of puriﬁ  ed 
recombinant WAVE2, 250 nM Abi1, PIR121 copuriﬁ  ed with 250 nM Nap1, and/or 500 nM IRSp53 were mixed, and Arp2/3 complex activation was 
measured in the absence of liposomes. (F) Effect of 15 μM GTPγS-loaded Rac on Arp2/3 activation in the absence of liposomes.WAVE2 COMPLEX FROM THE CYTOSOL AND MEMBRANE • SUETSUGU ET AL. 581
PIP3, indicating that PIP3, Rac, and IRSp53 are required for the 
activation of WAVE2.
We also examined the activation of the reconstituted 
WAVE2 complex. Abi1, Nap1, and PIR121 did not show the ac-
tivation of WAVE2 (Fig. 7 B). Lack of PIP3, Rac, and/or IRSp53 
decreased the activation of WAVE2. Cdc42 failed to activate the 
reconstituted WAVE2 complex in the presence of IRSp53 and 
PIP3-containing liposomes (unpublished data). PIP3-containing 
liposomes alone were not suffi  cient for activation of the WAVE2 
complex. Rac did not activate the reconstituted WAVE2 in the 
presence of liposomes (Fig. 7 B).
To confi   rm the PIP3- and Rac-dependent activation of 
WAVE2 by IRSp53, various concentrations of IRSp53 were ex-
amined (Fig. 7 C). In the presence of PC/PI, IRSp53 did not acti-
vate WAVE2. However, in the presence of Rac and PIP3/PC/PI, 
IRSp53 activated WAVE2 in a concentration-dependent manner. 
Thus, Rac requires IRSp53 to activate WAVE2 in the presence of 
liposomes. The A5 mutant of WAVE2, which is defective in PIP3 
binding (Oikawa et al., 2004), failed to be activated by IRSp53 
in the presence of Rac and PIP3-containing liposome (Fig. 7 D).
Interestingly, IRSp53 alone activated WAVE2 in the ab-
sence of liposomes or the PIP3-binding ability of WAVE2 (Fig. 7, 
C–E). Indeed, the activation of WAVE2 by IRSp53 was much 
stronger in the absence of liposomes (Fig. 7 C). Thus, liposomes 
may titrate out IRSp53 from WAVE2 by a nonspecifi  c IRSp53–
lipid association. PIP3 and Rac may then aid the association 
  between IRSp53 and WAVE2 in the presence of liposomes.
In the absence of liposomes, Abi1, Nap1, and PIR121 
showed no signifi  cant WAVE2 activation (Fig. 7 F). The addi-
tion of Rac to WAVE2 alone or the reconstituted WAVE2 com-
plex did not affect actin polymerization in the absence of 
liposomes (Fig. 7 F and not depicted).
IRSp53 binds to lipid via the RCB domain
PIP3-dependent activation of WAVE2 by Rac and IRSp53 indi-
cates that IRSp53 also binds to lipids. The crystal structure of 
the NH2-terminal domain of IRSp53, termed the IMD or RCB 
domain, has been reported previously (Millard et al., 2005). 
The overall surface of the IMD is positively charged, suggest-
ing that the IMD binds to the electronegative inner leafl  et of the 
cell membrane. We determined the binding of the RCB domain, 
the shorter fragment of the IMD, to lipids by ELISA (Oikawa 
et al., 2004), in which various lipids were coated onto plates. 
The RCB domain bound to almost all of the lipid species, with 
increased binding corresponding to increased negative charges 
(Fig. 8 B). The RCB domain bound strongly to phosphatidyl-
serine or weakly to PI, which are abundant lipids of the cell 
membrane (Fig. 8 B). The affi  nity of the RCB domains to vari-
ous lipids indicated the nonselective binding of the RCB domain 
to the membrane. In the liposome cosedimentation assay, where 
bound proteins to the liposome were examined, no difference in 
affi  nity was observed between PIP3-containing liposomes and 
PIP3-lacking liposomes (Fig. 8 C and not depicted). Without 
  liposome, only a trace amount of RCB protein was found in the 
precipitates (Fig. 8 D). Therefore, although RCB domain bound 
to negatively charged lipids, there was no selective binding of 
the RCB domain to PIP3 or other phosphoinositides. IRSp53 ap-
pears to bind to the cell membrane via electrostatic interactions 
between the RCB domain and membrane.
Rac- and PIP3-dependent association 
between WAVE2 and IRSp53 
in the presence of liposomes
We next examined the association of Rac, IRSp53, and WAVE2 
with PIP3-containing liposomes. Recombinant IRSp53 bound 
to PIP3/PC/PI liposomes (Fig. 9, A–C) but also bound to PC/PI 
liposomes at this concentration. Rac purifi  ed from Sf9 cells also 
associated with liposomes, presumably through lipid modifi  ca-
tion (Fig. 8, A and B; Hall, 1998). WAVE2 alone also bound to 
PIP3 (Oikawa et al., 2004), but in the presence of both activated 
(GTPγS loaded) Rac and IRSp53, the association of WAVE2 
with PIP3-containing liposomes increased fi  vefold (Fig. 9, A 
and C). Importantly, the increase in WAVE2 association in the 
presence of liposomes was not observed with GTPγS-loaded 
Cdc42, GDP-loaded Rac, or liposomes lacking PIP3 (Fig. 9, 
A–C). High molecular weight WAVE2 complex prepared by 
Figure 8.  Association of IRSp53 with lipids. (A) Domain structure of 
IRSp53. (B) Quantiﬁ  cation of the phosphoinositide-binding abilities of the 
RCB domain. ELISA was performed with GST as a negative control and 
GST-AktPH as positive controls. 1.0 μg ml
−1 GST-tagged proteins were 
overlaid on lipid vesicles (PE/PC/PIXP, PA, or phosphatidylserine [PS] = 
1:1:0.2  μg). Error bars represent SD of at least three independent 
experiments. PA, phosphatidic acid; PE, phosphatidyl ethanolamine. 
(C) Liposome binding by the RCB domain. Liposomes (PC/PI/PIP3  = 
48:48:4 or PC/PI = 50:50) were mixed with the RCB protein at the indi-
cated concentrations. The proteins that cosedimented with the liposomes 
were visualized. (D) Negative control of C without liposome at a 1.5-μM 
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sucrose gradient from A431 cells stably expressing FLAG-
WAVE2 also bound to PIP3 in the presence of IRSp53 and Rac 
(Fig. 9 E). Thus, PIP3 and Rac appear to greatly enhance the as-
sociation between IRSp53 and WAVE2 or the WAVE2 complex 
on liposomes or cell membrane. The actin polymerization assay 
on PIP3- or PI-coated beads confi  rmed the PIP3-dependent as-
sociation and activation of WAVE2 (Fig. S5, available at http://
www.jcb.org/cgi/content/full/jcb.200509067/DC1).
Discussion
In this study, we showed that IRSp53 is involved for the activa-
tion of WAVE2 in the membrane fraction of cells. IRSp53 was 
signifi  cantly concentrated in the membrane fraction, whereas 
WAVE2, Abi1, Nap1, and Sra1 were not. We also showed that 
both the WAVE2 complex from cells and the reconstituted 
WAVE2 complex could be fully active. IRSp53 enhanced the 
activation of WAVE2 in the absence of liposomes. However, 
Rac possesses a lipid modifi  cation and exists at the membrane, 
and IRSp53 induced the Rac-dependent activation of WAVE2 
or WAVE2 complex only in the presence of PIP3-containing 
 liposomes.  Therefore,  PIP3 at the membrane is essential for the 
Rac-dependent association of IRSp53 and WAVE2. In the pres-
ence of liposomes lacking PIP3, the weak binding of WAVE2 to 
liposomes inhibited its activation by IRSp53. Cdc42, another 
small GTPase that binds to IRSp53, weakened the association 
between IRSp53 and WAVE2.
Regulation of WAVE2 and actin 
cytoskeletal reorganization
Our experiments did not detect differences in WAVE2 activity 
in Arp2/3 activation between no stimulation, EGF stimulation 
Figure 9.  Rac- and PIP3-dependent actin polymerization 
mediated by IRSp53 and WAVE2 on PIP3.  (A and B) 
  Protein–lipid association was monitored by cosedimenta-
tion assay. Cosedimented proteins with liposomes with or 
without PIP3 were examined by Western blot analysis. 
PIP3, WAVE2, IRSp53, Rac, and Cdc42 were included at 
concentrations of 8 μM, 60 nM, 60 nM, 300 nM, and 
300 nM, respectively. (C and D) Quantiﬁ  cation of pro-
teins bound to liposomes was determined by densitometry 
for IRSp53 (C) and WAVE2 (D). Error bars represent SD. 
(E) Lipid association of the WAVE2 complex puriﬁ  ed from 
the high molecular weight fraction of sucrose gradient 
fractionation from A431 cells was monitored by cosedi-
mentation assay. Cosedimented proteins with liposomes 
containing or lacking PIP3 were examined by Western 
blot analysis. GTPγS-loaded Rac and IRSp53 were added, 
and their effects were examined. sup, supernatant; 
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(Fig. 6), and stimulation in response to the expression of 
Rac CA (not depicted). The activity of WAVE2 from MEFs 
was not signifi  cantly increased upon stimulation (Fig. 6 C), 
  suggesting that overall WAVE2 activity remains constant be-
fore and after stimulation.
When we consider the relationship between membrane 
  localization and activation of WAVE2, EGF stimulation or 
  expression of Rac CA induced only a 15–20% increase in 
  membrane-bound WAVE2 in both A431 cells and MEFs (Fig. 3 
and not depicted), and membrane-localized WAVE2 comprised 
 60% of WAVE2 in Triton X-100 preparations (Fig. 3). Thus, 
only an  10% increase in membrane WAVE2 in the Triton 
X-100 fraction appears to occur upon EGF stimulation. If EGF 
stimulation activates WAVE2 by inducing the membrane trans-
location of WAVE2, it may be too small to be detected in actin 
polymerization assays with WAVE2 prepared from whole cells.
Possible regulation of WAVE2 
by localization via formation of the WAVE2 
complex and enhancement of its activity 
by IRSp53
We did not detect differences in WAVE2 activity from cells, as 
discussed in the previous section, but we were able to reconsti-
tute Rac-dependent WAVE2 activation and found that IRSp53 
associated with the membrane. IRSp53 possesses an NH2-
  terminal RCB domain that is also called the IMD. Electrostatic 
interaction may account for the nonspecifi  c binding of IRSp53 
to the membrane (Fig. 8). Rac is also lipidated, and activated 
Rac is thought to function at the membrane. Therefore, PIP3 pro-
duction may simultaneously activate Rac and recruit WAVE2. 
Because IRSp53 bound to the membrane without specifi  c bind-
ing to phosphoinositides, IRSp53 is thought to constitutively 
bind to the membrane. Activated Rac may recruit IRSp53 to 
sites of PIP3 production, where WAVE2 is also recruited. Thus, 
PIP3 production may increase the possibility of IRSp53–WAVE2 
association at the membrane, resulting in membrane protrusion.
Kinetic analysis and sucrose gradient fractionation re-
vealed that the association of IRSp53 and WAVE2 is very transient. 
IRSp53 was copurifi  ed with WAVE2, but during sucrose gradi-
ent fractionation, the majority of IRSp53 appeared to dissociate 
(Fig. 5). This transient association between IRSp53 and WAVE2 
may be involved in the signal-dependent activation of WAVE2. 
Recently, Tiam1, a Rac guanine nucleotide exchange factor, 
was reported to enhance the association between IRSp53 
and WAVE2 (Connolly et al., 2005). Although we failed to 
  detect Tiam1 in the WAVE2 complex by Western blotting, pre-
sumably because of indirect association (unpublished data), 
proteins such as Tiam1 may participate in the effi  cient activa-
tion of WAVE2.
In contrast to the association of IRSp53 with WAVE2, the 
WAVE2 complex was very stable, at least in vitro. As reported 
earlier, Sra1/PIR121, Nap1, and Abi1 binds to Rac, Nck, and 
Abl, respectively (Eden et al., 2002; Echarri et al., 2004; 
  Innocenti et al., 2004; Steffen et al., 2004). We did not observe 
the dissociation of the WAVE2 complex upon the addition of 
Rac or Nck or upon simultaneous addition of IRSp53, PIP3, and 
Rac (Fig. 5 and not depicted). Phosphorylation of WAVE2 by 
Abl has also been reported to play a role in WAVE2 activation 
(Leng et al., 2005). However, we did not detect any difference 
in WAVE2 activity upon EGF stimulation in the presence or ab-
sence of STI-571, an Abl inhibitor (unpublished data). It has 
also been reported that Abl is involved in Rac activation and that 
ruffl  e formation downstream of Rac is independent of Abl fam-
ily kinase activity (Sini et al., 2004). However, Abl-mediated 
phosphorylation of WAVE2 may be involved in other cells. In 
our experiments, the knockdown of IRSp53 did not induce 
defects in lamellipodium formation as severe as those induced 
by the knockdown of Abi1 (Figs. 1 and 2, and Video 1). WAVE2 
is essential for the invasion of epithelial cells by Salmonella, 
and increased IRSp53 binding to WAVE2 was reported upon 
Salmonella infection (Shi et al., 2005). However, IRSp53 was 
not essential for the invasion itself. These results indicate that 
WAVE2 is regulated mainly by its localization via formation of 
the WAVE2 complex (Innocenti et al., 2004; Steffen et al., 2004). 
Therefore, IRSp53 may optimize WAVE2 activity by enhancing 
its activation of the Arp2/3 complex.
In a previous study of the WAVE1 protein complex in the 
brain, dissociation of WAVE1 from the partial protein complex 
of Abi, Nap1, and Sra1/PIR121 was observed upon incubation 
with Rac or Nck, and the WAVE1 complex alone was sub-
stantially inactive, suggesting the activation of WAVE1 upon 
dissociation from the complex (Eden et al., 2002). We have also 
observed that cytosolic WAVE2 had less activity than mem-
brane-bound WAVE2 from A431 cells and MEFs. Also, we 
found that the WAVE2 complex, both reconstituted and purifi  ed 
from cells, can be fully active without dissociation of the 
  complex. The reason for this discrepancy is not known, but it 
may be caused by different WAVE complex purifi  cation proto-
cols; Eden et al., (2002) used ammonium sulfate precipitation of 
the cytosolic fraction of the brain to purify WAVE1, whereas we 
immunoprecipitated WAVE2 directly from cell lysates. Protocol 
differences may result in the loss of unidentifi  ed complex com-
ponents that activate WAVE2 in our preparations. Alternatively, 
differences between WAVE1 and WAVE2 may be involved.
Materials and methods
Cells and puriﬁ  cation of the WAVE2 complex
A431 cells were transfected with FLAG-tagged WAVE2 in pCMV-Tag 2 
(Stratagene) or with vector alone. FLAG-tagged WAVE2 is functional be-
cause the transfection of FLAG-tagged WAVE2 into WAVE2 knockout cells 
eliminated WAVE2 deﬁ  cits. After selection with G418, cells with stable 
FLAG-WAVE2 expression were grown. These cells did not show any sig-
niﬁ  cant change in growth or appearance compared with vector-transfected 
cells or parental cells. The amount of FLAG-WAVE2 expression was similar 
to the amount of endogenous WAVE2. 10
6 cells were plated onto 15-cm 
dishes and cultured for 5 d. After serum starvation overnight, some cul-
tures were stimulated with EGF. To purify the WAVE2 complex from the 
cytosol (cytosol fraction), cells were harvested in buffer A containing 20 
mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 5 mM NaF, 1 mM 
Na3VO4, 1 mM PMSF, 10 μg/ml aprotinin, and 10 μg/ml leupeptin. To 
purify the WAVE2 complex, including that from the membrane fraction 
(Triton fraction), cells were harvested in buffer A supplemented with 1% 
Triton X-100 and 10% glycerol. Cells were sonicated and clariﬁ  ed by cen-
trifugation at 20,000 g for 20 min. The resulting supernatant was mixed 
with FLAG-agarose afﬁ  nity gel (Sigma-Aldrich). After being mixed for 1 h, 
gels were washed with buffer A supplemented with 0.5% Triton X-100 and 
10% glycerol and were washed with buffer XB containing 10 mM Hepes, 
pH 7.9, 100 mM KCl, 2 mM MgCl2, 0.2 mM CaCl2, and 5 mM EGTA. JCB • VOLUME 173 • NUMBER 4 • 2006  584
FLAG-WAVE2 complex was eluted with buffer XB plus 0.5 mg/ml FLAG 
peptide (Sigma-Aldrich). The eluted protein was analyzed or processed 
with sucrose gradient fractionation. 3–30% sucrose gradient was prepared 
in buffer XB supplemented with 10% glycerol, and the gradient was centri-
fuged at 200,000 g for 15 h. After sucrose gradient, the WAVE2 complex 
at high molecular weight fraction (typically fraction No. 8–10) was used for 
further experiments after concentration by the Ultrafree ﬁ  lter (Millipore).
Transfection and RNAi experiments
Cells were transfected with FuGene 6 (Roche). 10
6 cells in 15-cm dishes 
were cultured for 24 h, and these cells were transfected for 24 h and cul-
tured for 24 h. Cells were then starved overnight and used for assays. 
RNAi was performed as described previously with pSuper vector (Kurisu 
et al., 2005) or stealth RNAi (Invitrogen). The sequence of IRSp53 RNAi 
was G  G  A  G  C  T  G  C  A  G  T  A  C  A  T  C  G  A  C  . Abi1 RNAi was performed as de-
scribed previously (Steffen et al., 2004). Control RNAi was performed with 
pSuper vector with a sequence that caused no reduction of protein expression. 
Transfection efﬁ  ciency  was   80% when monitored by transfection with 
GFP-expressing plasmid. For cotransfection with WAVE2-GFP (Suetsugu 
et al., 2003), WAVE2-GFP and RNAi vector plasmids were mixed at 1:4 
ratios to ensure the cotransfection of GFP-positive cells. Rac G12V and 
Cdc42 G12V were used as CA Rac and Cdc42, respectively, and were 
expressed in the pEF-BOS vector (Suetsugu et al., 2003). IRSp53 was 
tagged with Venus, a brighter variant of GFP (Nagai et al., 2002).
siRNA was performed with stealth RNAi (Invitrogen). The siRNA 
sequence targeting was as follows: IRSp53 #1, 5′-A  G  U  A  C  U  C  G  G  A  C  A  A-
G  G  A  G  C  U  G  C  A  G  U  A  -3′;  IRSp53 #2, 5′-A  C  U  C  G  G  A  C  A  A  G  G  A  G  C  U  G  C  A  G  U-
A  C  A  U  -3′; IRTKS #1, 5′-C  A  A  U  C  C  U  G  G  G  C  U  G  C  G  A  A  A  U  U  U  A  A  U  A  -3′; IRTKS 
#2, 5′-C  G  U  G  A  A  A  U  A  U  A  U  G  A  A  C  G  C  A  A  C  U  C  U  A  -3′; IRTKS #3, 5′-C  G  U  G  A-
A  A  U  A  U  A  U  G  A  A  C  G  C  A  A  C  U  C  U  A  -3′; IRTKS #4, 5′-C  A  A  G  G  A  A  G  C  C  G  A  A  A-
C  G  C  A  C  U  C  A  A  A  U  -3′; control #1, 5′-A  G  U  G  G  C  U  A  A  C  A  G  A  G  G  C  G  U  C  A  C  A  G  U  A  -3′; 
control #2, 5′-A  C  U  A  G  A  C  G  A  A  G  C  G  G  U  A  C  U  G  A  G  C  C  A  U  -3′; control #3, 
5′-C  A  A  G  U  C  C  G  G  C  G  U  A  A  G  U  U  A  A  U  U  C  A  U  A  -3′; control #4, 5′-C  A  A  G  A  A  G-
C  C  A  A  A  C  G  C  U  C  A  A  C  G  G  A  A  U  -3′; Abi1 #1, HSS115189 (Invitrogen); Abi1 
#2, HSS115190 (Invitrogen); and Abi1 #3, HSS115191 (Invitrogen). A431 
cells were transfected with 2.6 μl of 20 μM siRNA in 120 μl OPTI-MEM 
and 1.2 μl LipofectAMINE 2000 reagent (Invitrogen) in 120 μl OPTI-MEM 
in a six-well plate with 1 ml DME + 10% FCS. After 24 h, a second trans-
fection was performed, and the cells were cultured for 48 h and subjected 
to RT-PCR or various experiments. The mRNA from RNAi-treated A431 cells 
was isolated using TRIzol reagent (Invitrogen). A ﬁ  rst-strand cDNA was syn-
thesized from the mRNA by the SuperScript First-strand synthesis system for 
RT-PCR (Invitrogen). The PCR ampliﬁ  cation was performed using the ﬁ  rst-
strand cDNA. Ampliﬁ  cation conditions were as follows: 25 cycles of 30 s at 
95°C, 30 s at 60°C, 60 s at 72°C, and a ﬁ  nal extension of 10 min at 72°C. 
IRSp53 expression construct that was resistant for RNAi was prepared by 
g486a and c495a mutations.
Antibodies
Anti-IRSp53 and anti-Abi1 antibodies were raised by immunizing rabbits 
with full-length IRSp53 and Abi1 proteins puriﬁ  ed from Escherichia coli as 
GST fusion proteins. Anti-WAVE2 was raised as described previously 
(Yamazaki et al., 2003). Anti-GFP antibody was purchased from MBL Inter-
national Corporation, and anti-FLAG M2 antibody was obtained from 
Sigma-Aldrich. Cell staining was performed as described previously, and 
actin ﬁ  laments were stained with phalloidin (Suetsugu et al., 2003). Cells 
were then observed by confocal microscopy (Bio-Rad Laboratories). Anti-
IRTKS antibody (M051-3) was purchased from MBL International Corpora-
tion and was found to be anti-IRSp53 antibody (Fig. S1 B).
Cell fractionation
Cells were harvested in buffer A and sonicated. Lysates were clariﬁ  ed 
by centrifugation at 3,000 g for 30 min to remove nuclei and debris. 
Supernatants were then clariﬁ   ed by ultracentrifugation at 400,000 g for 
45 min. The resulting supernatant was the cytosol fraction, and the pellet was 
the membrane fraction. Both were mixed with SDS-PAGE sample buffer to 
the same ﬁ  nal volume, and the proteins were analyzed by Western blotting.
Recombinant proteins
All recombinant proteins were expressed in Sf9 cells with the Bac-to-Bac 
Baculovirus Expression System (Invitrogen). WAVE2 and Abi1 were tagged 
with GST at their COOH termini and expressed with pFastBac. PIR121 
was tagged with GST at its COOH terminus and was coexpressed with 
Nap1 in the pFastBac Dual vector. WAVE2 tagged with GST and Abi1 
were also coexpressed in the pFastBac Dual vector for better expression. 
Approximately half of WAVE2 that coexpressed with Abi1 was complexed 
with Abi1 after puriﬁ  cation. Proteins were puriﬁ  ed as described previously 
(Miki et al., 2000).
Determination of Kd value using a dual polarization interferometer
The interaction of WAVE2 with the coiled-coil region of Abi1 or the SH3 
domain of IRSp53 using a dual polarization interferometer was investi-
gated with AnaLight Bio 200 (Farﬁ  eld) as described previously (Oikawa 
et al., 2004). WAVE2 was cross-linked on sensortip coated with amine 
with BS3 cross-linker (Sigma-Aldrich). The Kd values were calculated from 
curve ﬁ  tting.
Actin polymerization assay
Actin polymerization assays were performed in XB buffer as described 
previously (Miki et al., 2000). The Arp2/3 complex was used at a concen-
tration of 50 nM.
Liposome cosedimentation assay and actin polymerization assay 
on PIP3-coated beads
PIP3, PC, and PI as well as PIP3-coated beads were obtained from Echelon 
Biosciences. Liposome cosedimentation assays were performed as de-
scribed previously (Oikawa et al., 2004). For actin ﬁ  lament formation as-
says on PIP3 beads, 40 μg/ml WAVE2-GST coexpressed with Abi1, 
100 μg/ml GST-IRSp53, and 30 μg/ml GTPγS- or GDP-loaded GST-Rac 
in 10 μl XB buffer were incubated with 2 μl PIP3-coated beads. WAVE2 
complex from A431 cells (0.5 μg/ml WAVE2) was also incubated with 
PIP3-coated beads and Rac. After incubation at room temperature for 
20 min, beads were washed with 100 μl XB buffer. Beads were then mixed 
with 50 μl XB buffer containing 50 nM Arp2/3 complex, 2 μM G-actin, 
2 mg/ml BSA, and 2 unit/ml rhodamine-labeled phalloidin (Invitrogen) 
on ice. After incubation for 20 min on ice, 10 μl of bead-containing solu-
tion was placed between 18 × 18-mm BSA-coated glass and slide glass. 
After 10 min at room temperature, actin ﬁ  laments were observed by phal-
loidin ﬂ  uorescence. Fluorescence intensity was calculated by ImageJ soft-
ware with the Oval proﬁ  le plug-in (National Institutes of Health).
Image acquisition and processing
All ﬂ  uorescent images were taken through a microscope (Eclipse E600; 
Nikon) with a confocal microscopy system (Radiance 2000; Bio-Rad Labo-
ratories) at room temperature. Fluorochromes used include AlexaFluor488, 
546, and 647 and rhodamine (all purchased from Invitrogen). A 60× NA 
1.40 oil immersion objective (Nikon) was used. Images were assembled 
with Adobe Photoshop. In each plate, photographs were cropped, and 
each ﬂ  uorochrome was adjusted identically for brightness and contrast to 
represent the observed images. Time-lapse images were taken through a 
phase-contrast microscope (Axiovert S100; Carl Zeiss MicroImaging, Inc.) 
with a camera (CCD-782-Y/HS; Princeton Instruments). A 40× NA 1.30 
FLUAR oil immersion objective (Carl Zeiss MicroImaging, Inc.) was used.
Western blotting and densitometry
The samples were electrophoresed in SDS-PAGE gels, transferred to polyvi-
nylidene diﬂ  uoride membrane, blocked with 5% nonfat dry milk in PBS 
and 0.1% Tween 20, incubated with primary antibodies, and incubated 
with alkaline-phosphatase–conjugated goat IgG secondary antibodies 
(Promega) followed by incubation with NBT/BCIP substrate (Roche). Result-
ing blots were scanned with a calibrated densitometer (GS-710; Bio-Rad 
Laboratories) and quantiﬁ  ed with ImageJ software.
Online supplemental material
Fig. S1 shows the WAVE2 complex and IRSp53 in A431 cells. Fig S2 shows 
the involvement of IRSp53 in rufﬂ  e formation in MEFs. Fig. S3 shows silver-
stained gel images of fractionated WAVE2 in Fig. 5 (F–K). Fig. S4 shows 
the reconstituted recombinant proteins used in this study. Fig. S5 shows 
the actin polymerization on PIP3-coated beads by the WAVE2 complex or 
WAVE2 in the presence of IRSp53 and Rac. Videos 1 and 2 show cells 
treated with RNAi under stimulation. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200509067/DC1.
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